Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis

Zhou, Y; Cui, GF; Xu, HW; Chun, J; Yang, DR; Zhang, Z; Yang, LH; Wang, JX; Wan, MJ; Calvisi, DF; Lin, SM; Chen, X; Wang, HC

Lin, SM (通讯作者)，Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian, Peoples R China.;Chen, X (通讯作者)，Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94110 USA.;Chen, X (通讯作者)，Univ Calif San Francisco, Liver Ctr, San Francisco, CA 94110 USA.;Chen, X (通讯作者)，Univ Hawaii, Canc Ctr, Liver Canc Lab, Honolulu, HI 96822 USA.;Wang, HC (通讯作者)，Sichuan Univ, West China Hosp, Dept Gen Surg, Div Liver Surg, Chengdu, Peoples R China.;Wang, HC (通讯作者)，Sichuan Univ, West China Hosp, Lab Liver Surg, Chengdu, Peoples R China.

CELL DEATH & DISEASE, 2023; 14 (7):

Abstract

Hepatocellular carcinoma (HCC) is a deadly malignancy with high genetic heterogeneity. TP53 mutation and c-MET activation are frequent events in human......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索